Groove Botanicals Inc. (GRVE) Common Equity (2011 - 2026)

Groove Botanicals has disclosed Common Equity across 12 years of filings, most recently posting -$1.5 million for Q2 2026.

• In Q2 2026, Common Equity fell 28.39% year-over-year to -$1.5 million; the TTM figure through Jun 2026 stood at -$1.5 million (down 28.39% YoY), while the FY2026 annual figure was -$1.5 million, down 32.29% from the prior year.
• Common Equity came in at -$1.5 million for Q2 2026 at Groove Botanicals, down from -$1.5 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of -$438298.0 in Q1 2023 to a low of -$1.5 million in Q2 2026.
• Average Common Equity over 5 years is -$929341.9, with a median of -$893938.5 recorded in 2024.
• Year-over-year, Common Equity declined 17.4% in 2023 and slumped 73.53% in 2024.
• Over 5 years, Common Equity stood at -$520883.0 in 2022, then decreased by 24.08% to -$646326.0 in 2023, then plunged by 58.41% to -$1.0 million in 2024, then plunged by 34.61% to -$1.4 million in 2025, then slipped by 12.04% to -$1.5 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were -$1.5 million in Q2 2026, -$1.5 million in Q1 2026, and -$1.4 million in Q4 2025.